Back
Glaukos Corp. 10K Form
Sell
41
GKOS
Glaukos Corp.
Last Price:
$121.03
Seasonality Move:
-5.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-07 | 10Q | GKOS/Glaukos Corp. Quarterly |
| 2020-05-07 | 10Q | GKOS/Glaukos Corp. Quarterly |
| 2020-03-02 | 10K | GKOS/Glaukos Corp. Annual |
| 2019-11-06 | 10Q | GKOS/Glaukos Corp. Quarterly |
| 2019-08-08 | 10Q | GKOS/Glaukos Corp. Quarterly |
| 2019-05-08 | 10Q | GKOS/Glaukos Corp. Quarterly |
Receive GKOS News And Ratings
See the #1 stock for the next 7 days that we like better than GKOS
GKOS Financial Statistics
Sales & Book Value
| Annual Sales: | $383.5M |
|---|---|
| Cash Flow: | $-11.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.41 |
| Price / Book: | 10.59 |
Profitability
| EPS (TTM): | -3.27100 |
|---|---|
| Net Income (TTM): | $-187.7M |
| Gross Margin: | $287.1M |
| Return on Equity: | -25.22% |
| Return on Assets: | -19.22% |
Glaukos Corp. Earnings Forecast
Key Glaukos Corp. Financial Ratios
-
The Gross Profit Margin over the past 12 years for GKOS is 74.86%.
-
The Selling, General & Administrative Expenses for GKOS have been equal to 68.10% of Gross Profit Margin.
-
The Research & Development expenses have been 35.58% of Revenue.
-
The Net Earning history of GKOS is -38.17% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 5 years.
Glaukos Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | GKOS |
| CUSIP: | 377322 |
| Website: | glaukos.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 4.69 |
| Quick Ratio: | 3.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 237.18 |
GKOS Technical Analysis vs Fundamental Analysis
Sell
41
Glaukos Corp. (GKOS)
is a Sell
Is Glaukos Corp. a Buy or a Sell?
-
Glaukos Corp. stock is rated a SellThe current Glaukos Corp. [GKOS] share price is $121.00. The Score for GKOS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.